Wacker Chemie Inkomsten in het verleden
Verleden criteriumcontroles 0/6
De winst van Wacker Chemie is gedaald met een gemiddeld jaarlijks percentage van -45.8%, terwijl de winst van de Chemicals -industrie jaarlijks daalde met 4.4%. De inkomsten zijn daalde met een gemiddeld percentage van 2.9% per jaar.
Belangrijke informatie
-45.84%
Groei van de winst
-45.88%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.41% |
| Inkomstengroei | -2.91% |
| Rendement op eigen vermogen | -20.60% |
| Nettomarge | -14.83% |
| Volgende winstupdate | 30 Jul 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • May 02
WCH: Future Returns Will Depend On Delivering Cautious 2026 Earnings Guidance
Analysts have lifted their fair value estimate for Wacker Chemie from €73.50 to about €81.43, citing updated assumptions on revenue growth, profitability and future P/E multiples following several recent upgrades and price target increases from major research houses. Analyst Commentary Bullish Takeaways Bullish analysts point to a series of recent upgrades as support for a higher fair value range, linking their stance to refreshed assumptions on revenue, margins and the P/E multiple they are willing to apply.
Narratiefupdate • Apr 17
WCH: Supportive Research Tone Will Sustain Richer Future P/E Expectations
Analysts have nudged the fair value estimate for Wacker Chemie up to €96.00 from about €95.45, citing a higher assumed revenue growth rate, a revised future P/E of roughly 20.7, and a series of recent price target increases and upgrades from major banks. Analyst Commentary Recent Street research has tilted more supportive, with several bullish analysts revising their views in a way that reinforces the higher fair value estimate and the assumed future P/E of about 20.7. Some have raised price targets, including one increase to €61 from €59 alongside an Underweight rating, while others have moved to more positive stances through upgrades and more constructive commentary.Narratiefupdate • Apr 02
WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance
Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.
Narratiefupdate • Mar 18
WCH: Higher P/E Assumptions Will Likely Fail To Support Rich Share Price
Analysts have lifted their price target on Wacker Chemie to €61 from €59, reflecting updated views on revenue growth, profit margins and future P/E assumptions, while keeping the fair value estimate unchanged. Analyst Commentary Recent research on Wacker Chemie points to a mixed backdrop, with some price target adjustments reflecting caution around execution risks, earnings visibility and how the shares are valued against these factors.Narratiefupdate • Mar 04
WCH: Margin Execution Risks Will Likely Cap Share Upside Despite Upgrades
Analysts have raised their price target on Wacker Chemie to €50, citing firmer margin expectations and a lower assumed future P/E, supported by recent upgrades from major houses. Analyst Commentary Recent research reports on Wacker Chemie point to a more constructive view on margins and valuation, but you still see a strand of caution in the background.Narratiefupdate • Feb 18
WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple
Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.Narratiefupdate • Feb 03
WCH: Fair Outlook Will Depend On Restructuring Progress And Section 232 Resolution
Analysts have nudged their fair value estimate for Wacker Chemie higher to €69.57 from €67.36, reflecting updated views on margins and P/E assumptions, alongside mixed rating actions from recent Street research. Analyst Commentary Recent Street research shows a split view on Wacker Chemie, with some analysts turning more positive while others take a more cautious stance around execution and policy risks.Narratiefupdate • Jan 20
WCH: Section 232 Uncertainty Will Likely Cap Near Term Share Upside
Analysts have adjusted their average price target for Wacker Chemie to €73, reflecting a more cautious stance that aligns with recent Neutral and Equal Weight views as they wait for clarity on Section 232 outcomes and the company’s restructuring plans. Analyst Commentary Recent commentary around Wacker Chemie has taken a more cautious tone, with coverage starting at a neutral stance and an existing recommendation cut back to Neutral alongside a €73 price target.Narratiefupdate • Jan 06
WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome
Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.Analyseartikel • Jan 05
Revenues Tell The Story For Wacker Chemie AG (ETR:WCH)
With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...Narratiefupdate • Dec 18
WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares
Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.Narratiefupdate • Dec 04
WCH: Future Performance Will Depend On Restructuring Progress And Section 232 Decisions
Analysts have trimmed their fair value estimate for Wacker Chemie by roughly EUR 1 to about EUR 67. This reflects slightly softer growth expectations and more cautious price targets following a wave of Neutral and Hold ratings.Narratiefupdate • Nov 20
WCH: Near-Term Performance Will Depend On Restructuring Progress And Policy Outcomes
Wacker Chemie's analyst price target has seen a modest decrease to €68.29 from €69, as analysts cite cautious outlooks regarding restructuring progress and ongoing external uncertainties. Analyst Commentary Recent analyst activity on Wacker Chemie has provided a spectrum of perspectives on the company’s outlook, as reflected in their updated ratings and price targets.Narratiefupdate • Nov 05
WCH: Future Earnings Will Face Margin Pressure As Cautious Outlook Persists
Wacker Chemie’s fair value estimate has been raised from €66.33 to €69.00. This change reflects analysts’ updated outlook based on adjusted forecasts for discount rates, future revenue growth, and profit margins.Analyseartikel • Oct 26
What Is Wacker Chemie AG's (ETR:WCH) Share Price Doing?
Wacker Chemie AG ( ETR:WCH ), might not be a large cap stock, but it saw a decent share price growth of 13% on the XTRA...Narratiefupdate • Oct 22
Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts
Wacker Chemie's analyst price target has been revised downward from €68.92 to €66.33, with analysts citing slightly reduced expectations for revenue growth and profit margins as reasons for the change. Analyst Commentary Recent price target revisions for Wacker Chemie signal mixed sentiment in the market, as analysts evaluate the company’s prospects in light of changing expectations for revenue and profitability.Narratiefupdate • Oct 08
Polysilicon And Renewable Energy Investments Will Drive Future Value
Wacker Chemie's analyst price target has been revised downward, decreasing by approximately EUR 2.72 to EUR 68.92. Analysts note expectations for softer revenue growth and profit margins in their latest forecasts.Analyseartikel • Sep 29
Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narratiefupdate • Sep 19
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have lowered Wacker Chemie’s price target to €71.64, citing ongoing margin pressures, weak end-market demand, and reduced earnings visibility, driving a more cautious sector outlook. Analyst Commentary Bearish analysts cite continued margin pressures in key business segments, weighing on profit forecasts.Narratiefupdate • Sep 04
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have become more cautious on Wacker Chemie due to rising short-term earnings risks and macroeconomic uncertainty, resulting in price target downgrades and more conservative recommendations, with the consensus analyst price target unchanged at €75.79. Analyst Commentary Bearish analysts cite increased short-term risks to Wacker Chemie’s earnings momentum as a key factor behind lowered price targets.Analyseartikel • Sep 02
Wacker Chemie AG's (ETR:WCH) Business Is Yet to Catch Up With Its Share Price
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...Analyseartikel • Aug 03
Analyst Estimates: Here's What Brokers Think Of Wacker Chemie AG (ETR:WCH) After Its Half-Yearly Report
It's been a mediocre week for Wacker Chemie AG ( ETR:WCH ) shareholders, with the stock dropping 10% to €64.00 in the...Analyseartikel • Jun 20
Should You Think About Buying Wacker Chemie AG (ETR:WCH) Now?
While Wacker Chemie AG ( ETR:WCH ) might not have the largest market cap around , it received a lot of attention from a...Analyseartikel • May 30
Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Nieuw narratief • Dec 22
Specialty Silicones And Biosolutions Expansion Will Propel Earnings And Boost Net Margins
Investment in specialty silicones and focus on high-margin specialties forecast improved net margins and earnings through enhanced portfolio management.Opbrengsten en kosten
Opbrengsten en kosten
Hoe Wacker Chemie geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 26 | 5,413 | -803 | 555 | 210 |
| 31 Dec 25 | 5,485 | -821 | 564 | 215 |
| 30 Sep 25 | 5,566 | 22 | 574 | 214 |
| 30 Jun 25 | 5,656 | 136 | 584 | 213 |
| 31 Mar 25 | 5,711 | 189 | 585 | 209 |
| 31 Dec 24 | 5,722 | 241 | 574 | 204 |
| 30 Sep 24 | 5,770 | 124 | 560 | 199 |
| 30 Jun 24 | 5,863 | 124 | 544 | 194 |
| 31 Mar 24 | 6,148 | 214 | 541 | 190 |
| 31 Dec 23 | 6,402 | 314 | 540 | 184 |
| 30 Sep 23 | 6,846 | 515 | 553 | 183 |
| 30 Jun 23 | 7,456 | 739 | 567 | 184 |
| 31 Mar 23 | 7,877 | 1,002 | 559 | 182 |
| 31 Dec 22 | 8,209 | 1,251 | 548 | 178 |
| 30 Sep 22 | 8,071 | 1,292 | 527 | 173 |
| 30 Jun 22 | 7,597 | 1,299 | 502 | 165 |
| 31 Mar 22 | 6,924 | 1,087 | 488 | 165 |
| 31 Dec 21 | 6,208 | 807 | 475 | 164 |
| 30 Sep 21 | 5,758 | 582 | 458 | 157 |
| 30 Jun 21 | 5,283 | 403 | 460 | 161 |
| 31 Mar 21 | 4,854 | 227 | 458 | 157 |
| 31 Dec 20 | 4,692 | 189 | 458 | 157 |
| 30 Sep 20 | 4,609 | -619 | 495 | 173 |
| 30 Jun 20 | 4,693 | -599 | 474 | 160 |
| 31 Mar 20 | 4,889 | -568 | 495 | 173 |
| 31 Dec 19 | 4,928 | -643 | 495 | 173 |
| 30 Sep 19 | 4,961 | 135 | 508 | 177 |
| 30 Jun 19 | 4,936 | 117 | 509 | 175 |
| 31 Mar 19 | 4,997 | 163 | 505 | 171 |
| 31 Dec 18 | 4,979 | 246 | 496 | 165 |
| 30 Sep 18 | 4,966 | 271 | 491 | 158 |
| 30 Jun 18 | 5,035 | 308 | 481 | 154 |
| 31 Mar 18 | 4,923 | 287 | 475 | 152 |
| 31 Dec 17 | 4,924 | 232 | 473 | 153 |
| 30 Sep 17 | 4,900 | 201 | 465 | 156 |
| 30 Jun 17 | 4,739 | 160 | 456 | 157 |
| 31 Mar 17 | 4,720 | 157 | 437 | 155 |
| 31 Dec 16 | 4,634 | 168 | 423 | 150 |
| 30 Sep 16 | 4,716 | 153 | 445 | 156 |
| 30 Jun 16 | 4,923 | 154 | 456 | 162 |
| 31 Mar 16 | 5,094 | 208 | 475 | 168 |
| 31 Dec 15 | 5,296 | 247 | 490 | 175 |
| 30 Sep 15 | 5,258 | 225 | 474 | 179 |
| 30 Jun 15 | 5,132 | 285 | 465 | 180 |
Kwaliteitswinsten: WCH is momenteel verliesgevend.
Groeiende winstmarge: WCH is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: WCH is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 45.8% per jaar.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van WCH over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: WCH is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Chemicals industrie ( -13.5% ).
Rendement op eigen vermogen
Hoge ROE: WCH heeft een negatief Return on Equity ( -20.6% ), omdat het momenteel verliesgevend is.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/22 19:49 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Wacker Chemie AG wordt gevolgd door 31 analisten. 13 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Gerhard Schwarz | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Laura Lopez Pineda | Baader Helvea Equity Research |